ArticlePharmacological reports : PR2026
Tetrahydrocurcumin suppresses FcεRI- and MRGPRX2-mediated mast cell activation and attenuates peanut-induced anaphylaxis in an in vitro and in vivo study.
Gyeongseo Suk et al.PubMed ↗Publisher ↗
No numbers read from the abstract.